S2Medical AB (publ) (STO:S2M)

S2Medical AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Revenue	16.13	14.68	7.72	6.16	10.63
Revenue	16.13	14.68	7.72	6.16	10.63
Revenue Growth (YoY)	9.89%	90.03%	25.39%	-42.08%	-61.98%
Cost of Revenue	2.09	0.77	2.69	0.99	3.54
Gross Profit	14.04	13.91	5.04	5.17	7.1
Selling, General & Admin	15.45	14.99	19.14	31.54	25.54
Other Operating Expenses	-0.02	-7.22	-0.57	-0.61	-0.1
Operating Expenses	16.71	9.08	20.3	32.85	26.93
Operating Income	-2.66	4.83	-15.26	-27.69	-19.84
Interest Expense	-0.01	-0.02	-7.44	-1.77	-0.24
Interest & Investment Income	-	0	0	-	-
EBT Excluding Unusual Items	-2.67	4.81	-22.71	-29.46	-20.08
Gain (Loss) on Sale of Investments	-7.42	-	-	-	-
Pretax Income	-10.09	4.81	-22.71	-29.46	-20.08
Net Income	-10.09	4.81	-22.71	-29.46	-20.08
Net Income to Common	-10.09	4.81	-22.71	-29.46	-20.08
Shares Outstanding (Basic)	857	560	121	24	15
Shares Outstanding (Diluted)	857	560	121	24	15
Shares Change (YoY)	53.03%	360.86%	411.02%	60.30%	26.41%
EPS (Basic)	-0.01	0.01	-0.19	-1.24	-1.35
EPS (Diluted)	-0.01	0.01	-0.19	-1.24	-1.35
Free Cash Flow	0.68	5.03	-16.52	-28.34	-19.85
Free Cash Flow Per Share	0.00	0.01	-0.14	-1.19	-1.34
Gross Margin	87.07%	94.79%	65.22%	83.86%	66.74%
Operating Margin	-16.50%	32.89%	-197.63%	-449.53%	-186.54%
Profit Margin	-62.57%	32.78%	-294.00%	-478.23%	-188.83%
Free Cash Flow Margin	4.18%	34.28%	-213.89%	-460.08%	-186.70%
EBITDA	-1.39	5.52	-14.14	-26.37	-18.73
EBITDA Margin	-8.59%	37.61%	-183.02%	-	-176.11%
D&A For EBITDA	1.28	0.69	1.13	1.32	1.11
EBIT	-2.66	4.83	-15.26	-27.69	-19.84
EBIT Margin	-16.50%	32.89%	-197.63%	-	-186.54%
Revenue as Reported	16.89	22.33	8.45	8.93	11.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.